Sort
39,280 grants matching “leukemia”
Telomere Diseases
$2,219,794Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Studies of Occupational Cancer
$2,216,445Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
DNA Methylation & Chromatin Modifications: Mechanisms & Applications in Cancer*
$2,215,284Samson T Jacob · Ohio State University · P01 · FY2007 · CA
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
$2,213,500Joseph Leach · Park Nicollet Institute · UG1 · FY2015 · CA
The Immunobiology of Marrow Allografts for Leukemia
$2,212,710Sloan-Kettering Institute For Cancer Res · P01 · FY2002 · CA
Developmental and Hyperactive Ras Tumor (DHART) SPORE
$2,208,392David W. Clapp · Indiana University Indianapolis · U54 · FY2024 · CA
SPORE: Targeted Therapies for Glioma
$2,207,927Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2023 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$2,207,796Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$2,206,479Brenda Marie Sandmaier · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
Systems Biology of Tumor Progression and Drug-Resistance
$2,204,251Andrea Califano · Columbia University Health Sciences · RC2 · FY2010 · CA
Evolutionary Dynamics of Brain, Lung, and Hematopoietic Tumors
$2,201,840Franziska Michor · Dana-Farber Cancer Inst · U54 · FY2010 · CA
Specialized Program of Research Excellence in Myeloma
$2,199,943Kenneth C Anderson · Dana-Farber Cancer Inst · P50 · FY2006 · CA
Developmental and Hyperactive Ras Tumor (DHART) SPORE
$2,198,683David W. Clapp · Indiana University Indianapolis · U54 · FY2021 · CA
Office of Cancer Genomics
$2,197,998John Niederhuber · Office Of The Director, Nci · ZIA · FY2009 · CA
Studies of Populations Exposed to Occupational Sources of Radiation
$2,197,975Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Genes and signals controlling mammalian hematopoiesis.
$2,197,848Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging
$2,196,358Rebecca Smith-Bindman · University Of California, San Francisco · R01 · FY2016 · CA
Evolutionary Dynamics of Brain, Lung, and Hematopoietic Tumors
$2,195,148Franziska Michor · Sloan-Kettering Inst Can Research · U54 · FY2009 · CA
Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain
$2,195,014James Jeffrey Sahn · 4e Therapeutics Inc. · U44 · FY2023 · NS
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$2,194,368Carl H. June · University Of Pennsylvania · P01 · FY2021 · CA
THERAPY OF AML
$2,192,972University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA
Novel Therapeutic Strategies in Human Myeloid Leukemias
$2,191,623D Gary Gilliland · Dana-Farber Cancer Inst · P01 · FY2006 · CA
Cellular and Molecular Studies of Bone Marrow Transplant
$2,189,353James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2019 · CA
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$2,188,622Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
IATRONGENIC CAUSES OF CANCER
$2,188,073University Of Southern California · P01 · FY2003 · CA